CNBCさんのインスタグラム写真 - (CNBCInstagram)「Pfizer’s coronavirus vaccine could be distributed to Americans before the end of the year if found to be safe and effective, CEO Albert Bourla said Sunday. ⁠ ⁠ The drugmaker should have key data from its late-stage trial for the FDA by the end of October, Bourla said during an interview on CBS. If the FDA approves the vaccine, the company is prepared to distribute “hundreds of thousands of doses,” he said. ⁠ ⁠ Because of the pandemic, U.S. health officials and drugmakers have been accelerating the development of vaccine candidates by investing in multiple stages of research even though doing so could be for naught if the vaccine ends up not being effective or safe. The U.S. pharmaceutical giant has been working alongside German drugmaker BioNTech. In July, the U.S. government announced it would pay the companies $1.95 billion to produce and deliver 100 million doses of their vaccine if it proves safe and effective. ⁠ ⁠ Link in bio.⁠」9月15日 6時01分